Seeking Alpha
All posts from Seeking Alpha
Seeking Alpha in Seeking Alpha - Read, Decide, Invest.,

Hospira Snapped Up By Pfizer For $17 Billion

hBy Clayton Browne

Merger mania continues in the pharmaceutical industry. Pharma giant Pfizer announced on Thursday, February 5th that it has come to an agreement to acquire leading injectable drug and biosimilars producer Hospira. The deal calls for Pfizer to pay $90 per Hospira share, valuing the company at just over $17 billion.

Pfizer's statement notes the deal is expected to be immediately accretive upon closing, accretive by $0.10-$0.12 per share in the first full year after the merger is final with additional accretion anticipated.

More on the Pfizer - Hospira deal

Pfizer noted its expanded portfolio of sterile injectable pharmaceuticals, including acute care and oncology injectables, as well as its biosimilars portfolio, together with GEP's branded sterile injectables, including anti-infectives, anti-inflammatories and cytotoxics, will create a leading global sterile injectables business.

Moreover, the addition of Hospira's biosimilars portfolio also reinforces GEP's growth strategy to build a broad portfolio… Read More …